|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2022
As of Aug 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Cash | |||||||||||||
| Restricted cash | |||||||||||||
| Accounts receivable, net | |||||||||||||
| Contingent consideration, current | |||||||||||||
| Fair market value share price | |||||||||||||
| Digital assets | |||||||||||||
| Investment in ETH fund | |||||||||||||
| Government remittances | |||||||||||||
| Promissory note receivable, current | |||||||||||||
| Prepaid expenses and other current assets | |||||||||||||
| Total current assets | |||||||||||||
| Investments | |||||||||||||
| Contingent consideration, non-current | |||||||||||||
| Promissory note receivable, non-current | |||||||||||||
| Property and equipment, net | |||||||||||||
| Goodwill | |||||||||||||
| Intangible assets, definite lived, net | |||||||||||||
| Intangible assets, indefinite lived | |||||||||||||
| Right-of-use assets | |||||||||||||
| Total assets | |||||||||||||
| Liabilities and Stockholders’ Equity | |||||||||||||
| Accounts payable | |||||||||||||
| Accrued expenses and other current liabilities | |||||||||||||
| Players liability account | |||||||||||||
| Deferred revenue | |||||||||||||
| Current portion of operating lease liability | |||||||||||||
| Line of credit | |||||||||||||
| Promissory notes payable, current | |||||||||||||
| Convertible debt carried at fair value, current | |||||||||||||
| Warrant liability | |||||||||||||
| Contingent purchase consideration, current | |||||||||||||
| Deferred purchase consideration | |||||||||||||
| Arbitration reserve | |||||||||||||
| Total current liabilities | |||||||||||||
| Convertible debt carried at fair value, non-current | |||||||||||||
| Contingent purchase consideration, non-current | |||||||||||||
| Deferred tax liability | |||||||||||||
| Operating lease liability | |||||||||||||
| Total liabilities | |||||||||||||
| Mezzanine equity | |||||||||||||
| Series A-3 Redeemable Convertible Preferred Stock | |||||||||||||
| Total Mezzanine equity | |||||||||||||
| Series A-1 convertible preferred stock ($0.0001 par value, 50,000,000 authorized, 0 and 3,433 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively) | |||||||||||||
| Series A-1 Convertible Preferred Stock | |||||||||||||
| Total series A-1 convertible preferred stock ($0.0001 par value, 50,000,000 authorized, 0 and 3,433 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively) | |||||||||||||
| Common stock ($0.0001 par value, 500,000,000 shares authorized, 13,107,284 shares issued, 12,828,853 shares outstanding and 12,258,344 shares issued, 12,128,495 shares outstanding as of September 30, 2026 and December 31, 2025, respectively) | |||||||||||||
| Additional paid-in capital | |||||||||||||
| Treasury stock | |||||||||||||
| Accumulated other comprehensive loss | |||||||||||||
| Non-controlling interest | |||||||||||||
| Accumulated deficit | |||||||||||||
| Total stockholders’ equity | |||||||||||||
| Total liabilities and stockholders’ equity | |||||||||||||
Loading...